HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Hale Selected Research

Michael Hale Research Topics

Disease

4Mucopolysaccharidosis II (Hunter Syndrome)
11/2023 - 09/2022
3Neoplasms (Cancer)
04/2024 - 11/2017
2Cognitive Dysfunction
09/2022 - 09/2022
1Colorectal Neoplasms (Colorectal Cancer)
10/2023
1Medically Unexplained Symptoms
09/2022
1Crohn Disease (Crohn's Disease)
01/2020
1Disease Progression
11/2017
1Melanoma (Melanoma, Malignant)
11/2017
1Acute Kidney Injury (Acute Renal Failure)
02/2014
1Rheumatic Fever (Acute Articular Rheumatism)
02/2011

Drug/Important Bio-Agent (IBA)

4idursulfaseFDA Link
11/2023 - 09/2022
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2024 - 11/2017
1Formaldehyde (Formol)FDA Link
10/2023
1EpiregulinIBA
10/2023
1Cetuximab (Erbitux)FDA Link
10/2023
1Irinotecan (Camptosar)FDA LinkGeneric
10/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2023
1Panitumumab (Vectibix)FDA Link
10/2023
1LigandsIBA
10/2023
1ParaffinIBA
10/2023
1AmphiregulinIBA
10/2023
1amsonic acid (DAS)IBA
09/2022
1Proteins (Proteins, Gene)FDA Link
01/2020
1ulixertinibIBA
11/2017
1Polymyxins (Polymyxin)IBA
02/2014
1Colistin (Coly-Mycin)FDA Link
02/2014
1polymyxin B nonapeptideIBA
02/2014
1Polymyxin B (Aerosporin)FDA LinkGeneric
02/2014
1Biomarkers (Surrogate Marker)IBA
02/2014
1Indicators and Reagents (Reagents)IBA
02/2011

Therapy/Procedure

2Therapeutics
10/2023 - 11/2017
1Drug Therapy (Chemotherapy)
10/2023
1Enzyme Replacement Therapy
09/2022